Prediction of the efficacy of first transarterial chemoembolization for advanced hepatocellular carcinoma via a clinical-radiomics model

Table 7 Comparison of the performance of different predictive models using the DeLong test in the training and validation cohorts

Cohort	Model comparison	P value
Training cohort	Clinical model vs radiomics model	< 0.023
	Clinical model vs combined model	< 0.015
	Radiomics model vs combined model	0.453
Validation cohort	Clinical model vs radiomics model	< 0.036
	Clinical model vs combined model	< 0.021
	Radiomics model vs combined model	0.632